Nuvalent, Inc. · 1 day ago
Vice President, Regulatory Affairs
Nuvalent is an exciting early-stage company focused on creating selective medicines for cancer patients. The Vice President of Regulatory Affairs will lead the development and execution of global regulatory strategies, oversee regulatory submissions, and manage interactions with health authorities to ensure compliance and efficient drug development.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Support the expansion of the regulatory department outside the US (EU and other geographies), including organizational planning, resource allocation, and alignment of global regulatory processes
Develop and lead global regulatory strategies aligned with corporate and program goals
Serve as the primary regulatory voice at the executive level, providing guidance on risks, opportunities, and development pathways
Anticipate regulatory challenges and implement proactive solutions to enable efficient drug development
Serve as the primary regulatory lead for strategic diagnostic partnerships; manage joint development plans, governance structures, and communication channels to ensure alignment and execution
Define and lead global strategies for CDx regulatory requirements, including co-development expectations, validation, submission pathways, and labeling impacts
Oversee all CDx regulatory strategy and submissions related to CDx development, including interactions with FDA CDRH and other diagnostic regulators in coordination with diagnostic partner, as appropriate
Ensure coordinated communication among Nuvalent teams, CDx partners and health authorities
Ensure regulatory readiness for launch, including labeling, risk mitigation, and post-market planning
Negotiate and maintain collaborative agreements with diagnostic partners, ensuring compliance and shared objectives
Support the Head of Regulatory Affairs and development teams in preparing rapid, high-quality responses to health authority inquiries, ensuring accuracy, consistency, and strategic alignment
Lead interactions with FDA, EMA, and global regulatory agencies, including meetings, written communication, and briefing materials
Ensure timely, well-organized management of all health authority questions, follow-up items, and commitments
Ensure regulatory activities adhere to global standards and guidelines (ICH, FDA, EMA)
Monitor evolving regulatory landscapes and provide guidance on new expectations and opportunities
Partner closely with Program Management, Clinical Development, CMC, Nonclinical, Medical, and Commercial functions to align regulatory plans with development strategies
Contribute to clinical trial design, endpoints, labeling strategies, and lifecycle planning
Qualification
Required
15+ years of regulatory affairs experience in biotech/pharma, with significant leadership in CDx or IVD development
Proven track record of successful regulatory submissions and approvals for CDx products, ideally in oncology
Expertise with major global submissions and late stage or approved programs
Demonstrated success leading regulatory strategy for oncology therapeutics
Strong leadership, strategic thinking, and executive communication skills
Benefits
Medical, dental, and vision insurance
401(k) retirement savings plan
Generous paid time off (including a summer and winter company shutdown)
Company
Nuvalent, Inc.
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets.
Funding
Current Stage
Public CompanyTotal Funding
$1.82BKey Investors
Bain Capital Life SciencesDeerfield
2025-11-18Post Ipo Secondary· $500M
2024-09-16Post Ipo Equity· $575M
2023-10-16Post Ipo Equity· $300M
Recent News
MarketScreener
2025-12-16
Company data provided by crunchbase